Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

investorenquiries@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

Cancer Therapeutics Research

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Pitt Street Research Life Science Conference: Investor Presentation

191128_Investor Presentation

Categories: Investor Presentations 2019, News & Announcements 2019By PharmAust 28/11/2019

Related posts

31 December, Top 20 Shareholders
31/12/2019

Expanded Site Recruitment for Monepantel Phase II Trial in Pet Dogs with Cancer
11/12/2019

29 November, Top 20 Shareholders
02/12/2019

Appendix 3B, Exercise of Options
19/11/2019

Appendix 3B – Exercise of Options
08/11/2019

Progress in Recruitment for Phase II Trial in Dogs
04/11/2019

Recent Articles

Chief Executive Officer Appointment
28/08/2023
Additional Phase 1 data suggest MPL may inhibit MND
22/08/2023
Cohort 3 Pharmacokinetics in MND Patients Completed
09/08/2023
Appendix 4C and Quarterly Update
31/07/2023

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust @pharmaust ·

4 Sep

Great spread on Louie the Beagle in @AustVetMag Australian Veterinarian Magazine - Spring Issue

https://simplebooklet.com/theaustralianveterinarianmagazine_spring_2023_issue21

Reply on Twitter 1698509346102010223 Retweet on Twitter 1698509346102010223 2 Like on Twitter 1698509346102010223 9 Twitter 1698509346102010223

PharmAust @pharmaust ·

2 Sep

PharmAust CEO Dr Michael Thurn spoke with @Biotech_Buzz from @StocksDownUnder and @PSR_Insights about the clinical success with our flagship drug, Monepantel (MPL)

🎥 https://youtu.be/oCfvzseRDxQ?si=iBZu_GMBIg5oSiMX

Reply on Twitter 1697769500807176530 Retweet on Twitter 1697769500807176530 2 Like on Twitter 1697769500807176530 13 Twitter 1697769500807176530

PharmAust @pharmaust ·

29 Aug

New CEO to take the helm as PharmAust progresses clinical studies

Reply on Twitter 1696342181496443106 Retweet on Twitter 1696342181496443106 2 Like on Twitter 1696342181496443106 7 Twitter 1696342181496443106

Load More

Copyright © 2023 PharmAust. All rights reserved.

nil

Website Design & Digital Marketing Perth by Total Click Solutions